Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Charles Foster, MD, is a Staff Physician in the Center for Pediatric Infectious Diseases, Pediatric Institute, Cleveland Clinic. Dr. Foster consults on children with general pediatric infectious disease problems. He has a special interest in the management of infections in children with compromised immune systems. He is the Medical Director for Pediatric Infection Control. His research interests focus on Quality and Patient Safety and the prevention of healthcare associated infections.
Dr. Foster received his Bachelor of Arts degree from Haverford College in Haverford, Pa., in 1986, and his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio, in 1991. He is a Diplomate of the American Board of Pediatrics and of the American Board of Pediatric Infectious Diseases.
From 1991 to 1994, he was Intern and Resident a the Johns Hopkins Hospital and completed a fellowship in general pediatrics a Johns Hopkins University in Baltimore, MD.
He received subspecialty training in Pediatric Hematology and Oncology, at the Pediatric Oncology Branch of the National Cancer Institute in Bethesda, Md., from 1994 to 1997.
From 1995 to 2002, Dr. Foster was a Clinical Fellow in the Immunocompromised Host Section/Section of Genomic Variation, at the Pediatric Oncology Branch of the National Cancer Institute. He also received subspecialty training in Pediatric Infectious Diseases at Johns Hopkins Hospital from 1999 to 2001.
Dr. Foster was Assistant Professor and Attending Physician in the Division of Pediatric Infectious Diseases, Department of Pediatrics, at Johns Hopkins University, from 2002-2006.
Congenital infections, epidemiology, infection control, infections in pediatric cancer patients, infections in immunocompromised hosts, infections in pediatric transplant recipients, pediatric infections, pediatric infectious diseases, pediatric viral infections, pediatric bacterial infections, pediatric fungal infections, healthcare associated infections, infectious diseases
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/2/2015, Dr. Foster has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.